These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Iatrogenic Creutzfeld-Jakob disease induced by the administration of extracted growth hormone]. Rev Neurol (Paris); 1993; 149(10):515-6. PubMed ID: 8023062 [No Abstract] [Full Text] [Related]
26. Eternal vigilance--mortality in children with growth hormone deficiency. Hintz RL J Clin Endocrinol Metab; 1996 May; 81(5):1691-2. PubMed ID: 8626816 [No Abstract] [Full Text] [Related]
27. [Treatment with extractive growth hormone and Creutzfeld-Jakob encephalopathy: a new iatrogenic tragedy]. Battin J Pediatrie; 1993; 48(2):91-5. PubMed ID: 8393184 [No Abstract] [Full Text] [Related]
28. The missing link. Eaton L Nurs Times; 1993 Sep 22-28; 89(38):19. PubMed ID: 8415073 [No Abstract] [Full Text] [Related]
29. Death from CJD a "misadventure". Brahams D Lancet; 1993 Nov; 342(8881):1229. PubMed ID: 7901539 [No Abstract] [Full Text] [Related]
30. Problems with growth hormone. Med Lett Drugs Ther; 1985 Jul; 27(691):57-8. PubMed ID: 3892258 [No Abstract] [Full Text] [Related]
31. Europe. Acquittals in CJD trial divide French scientists. Casassus B Science; 2009 Jan; 323(5913):446. PubMed ID: 19164711 [No Abstract] [Full Text] [Related]
32. The human growth hormone Creutzfeld Jakob disease litigation. Owen R Med Leg J; 1997; 65 ( Pt 2)():46-64. PubMed ID: 9241994 [No Abstract] [Full Text] [Related]
33. Creutzfeldt-Jakob disease following treatment with human pituitary hormones. Preece MA Clin Endocrinol (Oxf); 1991 Jun; 34(6):527-9. PubMed ID: 1889134 [No Abstract] [Full Text] [Related]
34. Human growth hormone treatment and Creutzfeldt-Jakob disease. Sartorio A; Arosio M; Faglia G; Resentini M; Morabito F J Endocrinol Invest; 1986 Oct; 9(5):439. PubMed ID: 3540083 [No Abstract] [Full Text] [Related]
35. [Slow-virus encephalitis in subjects treated with growth hormone extract: unexpected risks of substitute therapy]. Butturini L G Clin Med; 1986 Feb; 67(1):53. PubMed ID: 3539686 [No Abstract] [Full Text] [Related]
36. Human growth hormone distribution discontinued. FDA Drug Bull; 1985 Aug; 15(2):17-8. PubMed ID: 3902547 [No Abstract] [Full Text] [Related]
37. [Deficient routines in management of Creutzfeldt-Jakob disease]. Liungman O Lakartidningen; 2000 Aug; 97(35):3781-2. PubMed ID: 11016236 [No Abstract] [Full Text] [Related]
38. [Is there a causative relation between infectious degenerative encephalopathy and the use of growth hormone?]. Romer TE Pediatr Pol; 1986 Nov; 61(11):740-4. PubMed ID: 3295737 [No Abstract] [Full Text] [Related]
39. Creutzfeldt-Jakob disease in children treated with growth hormone. Billette de Villemeur TB; Beauvais P; Gourmelen M; Richardet JM Lancet; 1991 Apr; 337(8745):864-5. PubMed ID: 1672962 [No Abstract] [Full Text] [Related]
40. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(24):359-60, 365-6. PubMed ID: 3923319 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]